<?xml version="1.0"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
<channel>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
<description>BloggingStocks</description>
<image>
<url>http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif</url>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
</image>
<language>en-us</language>
<copyright>Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only.</copyright>
<generator>Blogsmith http://www.blogsmith.com/</generator><item><title><![CDATA[The 52-week high club]]></title><link>http://www.bloggingstocks.com/2007/12/14/the-52-week-high-club/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2007/12/14/the-52-week-high-club/</guid><comments>http://www.bloggingstocks.com/2007/12/14/the-52-week-high-club/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/after-the-bell/" rel="tag">After the Bell</a>, <a href="http://www.bloggingstocks.com/category/analyst-upgrades-and-downgrades/" rel="tag">Analyst Upgrades and Downgrades</a></p><p><a href="http://finance.aol.com/quotes/hess-corporation/hes/nys">Hess Corp.</a> (NYSE:<a href="http://finance.aol.com/quotes/hess-corporation/hes/nys">HES</a>): HES keeps rising with the price of oil. The stock was up to $86.46 against a 52-week low of $45.96.</p>
<p><a href="http://finance.aol.com/quotes/biomarin-pharmaceutical-inc/bmrn/nas">BioMarin Pharmaceutical Inc.</a> (NASDAQ:<a href="http://finance.aol.com/quotes/biomarin-pharmaceutical-inc/bmrn/nas">BMRN</a>): BioMarin is now able to charge more for new drug Kuvan than expected. Shares were up to $37.17 compared to 52-week low of $15.53.</p>
<p><a href="http://finance.aol.com/quotes/savient-pharmaceuticals-inc/svnt/nas">Savient Pharmaceuticals Inc.</a> (NASDAQ:<a href="http://finance.aol.com/quotes/savient-pharmaceuticals-inc/svnt/nas">SVNT</a>): Strong results from its new gout drug kept shares up second day in a row. It hit $19.40 against 52-week low of $10.58.</p>
<p><a href="http://finance.aol.com/quotes/rigel-pharmaceuticals-inc/rigl/nas">Rigel Pharmaceuticals Inc.</a> (NASDAQ:<a href="http://finance.aol.com/quotes/rigel-pharmaceuticals-inc/rigl/nas">RIGL</a>): An upgrade from Lehman came after strong results from drug trials. Shares spiked to $31 in contrast to 52-week low of $6.64.</p>
<p><em>Douglas A. McIntyre is an editor at </em>247wallst.com.</p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2007/12/14/the-52-week-high-club/">The 52-week high club</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Fri, 14 Dec 2007 18:19:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2007/12/14/the-52-week-high-club/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/1063367/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2007/12/14/the-52-week-high-club/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>biomarin</category><category>hess</category><category>rigel</category><category>savient</category><dc:creator><![CDATA[Douglas McIntyre]]></dc:creator><pubDate>Fri, 14 Dec 2007 18:19:00 EST</pubDate></item><item><title><![CDATA[Analyst initiations 7-19-07: AA, FFIV, ISIS and MINI]]></title><link>http://www.bloggingstocks.com/2007/07/19/analyst-initiations-7-19-07-aa-ffiv-isis-and-mini/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2007/07/19/analyst-initiations-7-19-07-aa-ffiv-isis-and-mini/</guid><comments>http://www.bloggingstocks.com/2007/07/19/analyst-initiations-7-19-07-aa-ffiv-isis-and-mini/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/before-the-bell/" rel="tag">Before the Bell</a>, <a href="http://www.bloggingstocks.com/category/analyst-reports/" rel="tag">Analyst Reports</a>, <a href="http://www.bloggingstocks.com/category/analyst-upgrades-and-downgrades/" rel="tag">Analyst Upgrades and Downgrades</a>, <a href="http://www.bloggingstocks.com/category/aa/" rel="tag">Alcoa Inc (AA)</a></p><strong><a href="http://www.theflyonthewall.com/splashPage.php?source=AOL"><img vspace="4" hspace="4" border="1" align="right" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2007/07/aol-fly-logo.gif"  alt="" /></a>MOST NOTEWORTHY: </strong> Alcoa (AA), Rigel Pharma (RIGL), Isis Pharma (ISIS), Cytokinetics (CYTK) and F5 Networks (FFIV) were today's noteworthy initiations: <br />
<ul>
    <li>RBC believes shares are expensive, but feels <a href="http://finance.aol.com/quotes/alcoa-inc/aa/nys?tabs=quotesandnews">Alcoa </a>(NYSE: <a href="http://finance.aol.com/quotes/alcoa-inc/aa/nys?tabs=quotesandnews">AA</a>) has put itself in play and a bid for the company is possible. The firm resumed coverage with a Sector Perform rating and a $51 target. </li>
</ul>
<ul>
    <li>Credit Suisse initiated <a href="http://finance.aol.com/quotes/rigel-pharmaceuticals-inc/rigl/nas?tabs=quotesandnews">Rigel Pharmaceuticals</a> (NASDAQ: <a href="http://finance.aol.com/quotes/rigel-pharmaceuticals-inc/rigl/nas?tabs=quotesandnews">RIGL</a>) with an Outperform rating, believing R788 in ITP alone justifies current value, while RA and pipeline provide potential upside. </li>
</ul>
<ul>
    <li><a href="http://finance.aol.com/quotes/isis-pharmaceuticals-inc/isis/nas?tabs=quotesandnews">Isis Pharmaceuticals </a>(NASDAQ: <a href="http://finance.aol.com/quotes/isis-pharmaceuticals-inc/isis/nas?tabs=quotesandnews">ISIS</a>) was initiated with a Buy rating and $17 target at Jefferies; the firm believes Isis's pipeline holds promise and appears under appreciated at the current valuation. </li>
</ul>
<ul>
    <li>Credit Suisse is positive on <a href="http://finance.aol.com/quotes/cytokinetics-incorporated/cytk/nas?tabs=quotesandnews">Cytokinetics </a>(NASDAQ: <a href="http://finance.aol.com/quotes/cytokinetics-incorporated/cytk/nas?tabs=quotesandnews">CYTK</a>) congestive heart failure candidate CK-453 and views the market as undeserved, starting shares with an Outperform rating and $15 target. </li>
</ul>
<ul>
    <li>Unterberg initiated shares of <a href="http://finance.aol.com/quotes/f5-networks-inc/ffiv/nas?tabs=quotesandnews">F5 Networks</a> (NASDAQ: <a href="http://finance.aol.com/quotes/f5-networks-inc/ffiv/nas?tabs=quotesandnews">FFIV</a>) with a Market Perform based on valuation... </li>
</ul>
<strong>OTHER INITIATIONS:</strong> <br />
<ul>
    <li>Credit Suisse initiated <a href="http://finance.aol.com/quotes/mobile-mini-inc/mini/nas?tabs=quotesandnews">Mobile Mini </a>(NASDAQ: <a href="http://finance.aol.com/quotes/mobile-mini-inc/mini/nas?tabs=quotesandnews">MINI</a>) with a Neutral rating. </li>
</ul>
<ul>
    <li><a href="http://finance.aol.com/quotes/art-technology-group-inc/artg/nas?tabs=quotesandnews">Art Technology </a>(NASDAQ: <a href="http://finance.aol.com/quotes/art-technology-group-inc/artg/nas?tabs=quotesandnews">ARTG</a>) was initiated with a Buy rating at Pacific Growth. </li>
</ul>
<ul>
    <li>Banc of America started <a href="http://finance.aol.com/quotes/grant-prideco-inc-w-i/grp/nys?tabs=quotesandnews">Grant Prideco </a>(NYSE: <a href="http://finance.aol.com/quotes/grant-prideco-inc-w-i/grp/nys?tabs=quotesandnews">GRP</a>) share with a Buy rating and $67 target. </li>
</ul>
<ul>
    <li>Morgan Joseph initiated <a href="http://finance.aol.com/quotes/harris-stratex-netwk-inc-cl-a/hstx/nas?tabs=quotesandnews">Harris Stratex Networks </a>(NASDAQ: <a href="http://finance.aol.com/quotes/harris-stratex-netwk-inc-cl-a/hstx/nas?tabs=quotesandnews">HSTX</a>) with a Buy rating.</li>
</ul>
<em>Analyst summaries provided by <a href="http://www.theflyonthewall.com/splashPage.php?source=AOL">TheFlyOnTheWall.com</a> (subscription required).</em><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2007/07/19/analyst-initiations-7-19-07-aa-ffiv-isis-and-mini/">Analyst initiations 7-19-07: AA, FFIV, ISIS and MINI</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Thu, 19 Jul 2007 11:15:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2007/07/19/analyst-initiations-7-19-07-aa-ffiv-isis-and-mini/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/944538/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2007/07/19/analyst-initiations-7-19-07-aa-ffiv-isis-and-mini/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>aa</category><category>alcoa</category><category>analyst</category><category>art technologies</category><category>artg</category><category>ArtTechnologies</category><category>cytk</category><category>f5</category><category>ffiv</category><category>grant prodeco</category><category>GrantProdeco</category><category>grp</category><category>harris stratex</category><category>HarrisStratex</category><category>initiation</category><category>isis</category><category>mini</category><category>rating</category><category>rigel</category><category>rigl</category><category>theflyonthewall.com</category><dc:creator><![CDATA[Kevin Shult]]></dc:creator><pubDate>Thu, 19 Jul 2007 11:15:00 EST</pubDate></item></channel></rss>
